New York Times SEC Filings

Director Arthur S. Golden filed a Form 4 for The New York Times Company (NYT) covering a routine dividend-equivalent adjustment dated 24 Jul 2025. He received 67 Class A RSUs at a deemed price of $0, reflecting cash dividends on previously awarded RSUs under the 2020 Incentive Compensation Plan. These dividend-equivalent RSUs are fully vested when linked to vested awards; otherwise, they vest on the next annual meeting date.

Following the transaction Golden directly owns 20,398 Class A shares. Indirectly, he continues to hold 1.4 million shares through a trust, 69,518 shares via his spouse (as trustee), and 42,073 shares via another trust. No shares were sold, and no derivatives were exercised or disposed of.

The filing represents a de minimis ownership increase (0.003% of his total reported holdings) and does not indicate any change in strategy or outlook for NYT. No financial performance data, guidance, or corporate events are disclosed.

Form 4 (filed 28 Jul 2025) reports Director Amanpal S. Bhutani’s receipt of 97 Class A RSUs in The New York Times Company (NYT) on 24 Jul 2025. The units were issued as dividend-equivalent RSUs under the 2020 Incentive Compensation Plan, mirroring cash dividends paid on existing equity awards. Transaction code A confirms an award at $0 cost. Post-transaction, Bhutani’s direct beneficial ownership rises to 29,531 shares.

No shares were sold and no derivatives were exercised, so the transaction is non-dilutive and has minimal effect on NYT’s share count or market float. While the grant is routine and quantitatively immaterial, continued insider accumulation—however small—can be interpreted as a modest signal of alignment with shareholders.

Bank of Hawaii (BOH) Q2-25 10-Q highlights:

• Net income rose 40% YoY to $47.6 m; diluted EPS up to $1.06 from $0.81.
• Net interest income increased 13% YoY to $129.7 m as higher loan yields offset deposit-rate pressure; interest expense fell 10% to $88.9 m.
• Provision for credit losses modest at $3.3 m (up $0.9 m YoY); allowance remains $148.5 m (1.06% of loans).
• Non-interest income grew 6% to $44.8 m, led by service charges and fee income; securities losses narrowed to $1.1 m.
• Efficiency: non-interest expense up just 1% YoY to $110.8 m despite wage inflation; FDIC special assessment impact eased (expense $3.6 m vs $7.2 m).
• Balance sheet: Assets $23.7 bn (+0.5% YTD); loans $14.0 bn (-0.5% YTD); deposits $20.80 bn (+0.8%). Time deposits remain 15% of mix. Liquidity strong with $769 m cash.
• Capital: Common equity up 5% YTD to $1.74 bn; AOCI loss improved to -$299 m from -$343 m on bond price recovery. CET1 ratio not disclosed in excerpt, but equity/assets at 7.4%.
• Shareholder returns: $0.70 common dividend maintained (payout 66% of Q2 earnings); preferred dividends $5.3 m.

Overall, BOH delivered solid YoY earnings growth, controlled expenses, and stable credit quality, while deposit funding stabilized in a high-rate environment.

On 07/24/2025, New York Times Company (NYSE: NYT) director Beth A. Brooke acquired 65 Class A shares in the form of dividend-equivalent restricted stock units (RSUs) granted under the 2020 Incentive Compensation Plan. The RSUs were issued at $0 cost, lifting her direct stake to 19,661 shares. Dividend-equivalent RSUs tied to already-vested awards are immediately vested; those related to unvested awards will vest at the company’s next annual meeting. No dispositions, options or derivative securities were reported. This appears to be a routine compensation event and is immaterial to the company’s capital structure.

• Transaction code: A (acquisition)
• Form filed by one reporting person
• Relationship: Director

Form 4 – The New York Times Company (NYT)

Director Rachel C. Glaser reported the automatic acquisition of 110 Class A common shares on 07/24/2025. The shares were issued as dividend-equivalent restricted stock units (RSUs) under the 2020 Incentive Compensation Plan and carry a reported cost of $0, reflecting cash dividends paid on previously held RSUs. After this transaction, Glaser directly owns 33,228 Class A shares.

The filing represents a routine, non-cash increase in the director’s equity stake with no accompanying sales, option exercises, or changes in board role disclosed.

Healthcare Services Group (HCSG) filed a Form 144 indicating the planned sale of 21,368 common shares on or about 07/28/2025 through Morgan Stanley Smith Barney on the NASDAQ. The shares carry an aggregate market value of $283,126, representing roughly 0.03% of the company’s 72.4 million shares outstanding.

The seller acquired the stock over several years via employee-related programs: employee stock purchase plans (2021 & 2022), restricted-stock grants (2016), and option exercises (2012-2015). The filer reports no sales during the prior three months and affirms possession of no undisclosed material adverse information, as required under Rule 144.

While Form 144 filings do not guarantee a transaction will occur, they often signal insider intent to dispose of shares. Given the modest size relative to float, the proposed sale is unlikely to have a material impact on liquidity or price dynamics.

On 07/25/2025, Gilead Sciences (GILD) EVP, Corporate Affairs & General Counsel Deborah H. Telman filed a Form 4 detailing routine equity-award settlements. Two restricted-stock unit (RSU) tranches vested, converting into 8,743 common shares (8,229 + 514) under transaction code “M”. To satisfy withholding taxes, 3,823 shares were automatically disposed of at $116.20 (code “F”). Net of the tax sale, Telman’s direct ownership increased by 4,920 shares to 42,721 shares.

Post-transaction, the executive still holds 51,521 unvested RSUs (29,875 + 21,646) that will vest over three- and four-year schedules. No open-market purchases or discretionary sales occurred; the filing reflects scheduled vesting rather than a valuation-driven trade. While the additional shares retained signal modest long-term alignment, the event is generally viewed as neutral for investors, providing limited insight into Gilead’s operational or financial outlook.

Form 4 filing for The New York Times Company (NYT) discloses a routine dividend-equivalent grant to director Anuradha B. Subramanian on 24 Jul 2025. The director received 32 Class A common shares in the form of fully vested Restricted Stock Units (RSUs) credited in lieu of cash dividends under the company’s 2020 Incentive Compensation Plan. No cash consideration was paid (price $0), and her direct ownership rose to 9,545 shares following the transaction. No derivative securities were reported. The filing is signed by an attorney-in-fact on 28 Jul 2025.

The transaction is administrative in nature, reflects standard board compensation mechanics, and represents an immaterial (~0%) change in outstanding shares.

On 07/24/2025 Adobe Inc. (ADBE) EVP & Chief People Officer Gloria Chen filed a Form 4 reporting routine RSU vesting. She converted 424 restricted stock units into common shares (Code M) at a $0 exercise price. To satisfy tax withholding she simultaneously disposed of 210 shares at $371.69 (Code F). The net 214-share increase lifts her direct ownership to 39,072.112 shares, while she also holds 667 shares indirectly via a family trust and retains 849 unvested RSUs. The underlying RSU grant vests 25 % on the first anniversary of 24 Jan 2022 and 6.25 % quarterly thereafter. All transactions were administrative; no open-market buying or selling is indicated. The filing contains no operational or financial guidance and is unlikely to affect Adobe’s fundamentals.